Beth C Seidenberg Atara Biotherapeutics, Inc. (ATRA) insider trading activity

Beth C Seidenberg is of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 115,689 shares of ATRA, which is worth approximately $891,962. The most recent transaction as insider was on May 31, 2023, when has been sold 57,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 116K

0% 3M change

0% 12M change

Total Value Held $891,962

BETH C SEIDENBERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2023	BUY Grant, award, or other acquisition	-	57,000 Added 33.01%	115,689 Common Stock
Jun 23 2022	BUY Grant, award, or other acquisition	-	20,500 Added 25.89%	58,689 Common Stock
Jun 08 2021	BUY Grant, award, or other acquisition	-	11,000 Added 22.36%	38,189 Common Stock

Also insider at

PGNY

Progyny, Inc. Healthcare

Director

VERA

Vera Therapeutics, Inc. Healthcare

SLRN

ACELYRIN, Inc.

Director

SGMT

Sagimet Biosciences Inc.

Director

KYTX

Kyverna Therapeutics, Inc.

BCS